SecBot SecBot
3 ·Filed Nov 3, 2026

MRK

Merck & Co., Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed13d 9h ago SEC0000310158-26-000243
Form 3: initial insider ownership statement
Actionable Insight • Neutral

Routine initial ownership filing for a new insider. No trading signal. Monitor future Form 4 filings for any open-market purchases or sales by Diaz.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$144.67
T+0 close · Nov 3, 2026 · via day close
Latest settled
+2.34%
T+5 · $148.05
Vs SPY
+2.92%
α at T+5
Next horizon
T+20
in 15d
  1. T+0 · Nov 3 $144.67entry
  2. T+1 · 13d ago +3.93%α +2.28% · $150.36
  3. T+5 · 7d ago +2.34%α +2.92% · $148.05
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Paul J. Diaz filed a Form 3 initial statement of beneficial ownership with the SEC, reporting 200 shares of Merck common stock held directly and 96 shares held indirectly through a revocable trust. The filing is a routine Section 16 compliance requirement for a new officer or director and contains no material financial information.

Key Facts

  • Paul J. Diaz filed Form 3 on 2026-11-03, reporting beneficial ownership as of 2026-11-01.
  • Direct holdings: 200 shares of Merck common stock.
  • Indirect holdings: 96 shares held through Reporting Person's Revocable Trust.
  • The filing includes a Power of Attorney authorizing Jennifer Zachary, Jon Filderman, and Kelly Grez to file Section 16 reports on his behalf.

Financial Impact

No material financial impact; holdings of 296 shares are negligible relative to Merck's $361B market cap.

Risk Factors

  • No material risks identified; this is a standard compliance filing.

Market Snapshot

Price
$144.62
Volume
100
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
71% bullish (35 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0000310158-26-000243
Document: 0000310158-26-000243-index-headers.html0000310158-26-000243
Document: 0000310158-26-000243-index.html0000310158-26-000243
Document: 0000310158-26-000243.txt0000310158-26-000243

Track record

34 reports on MRK

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +16.92% at T+20 after the Aug 6, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 12, 20264d ago 144 Neutral 2/10 Entry $147.76 Now $144.46 −2.23% settles Feb 11
  2. Nov 9, 20268d ago PTAB Trial Neutral 2/10 Entry $148.05 Now $144.46 −2.42% settles Feb 8
  3. Nov 3, 202613d ago 3 Neutral 2/10 Viewing Entry $144.67 Now $144.46 −0.15% settles Feb 1
  4. Nov 3, 202613d ago Institutional Cluster Bearish 4/10 Entry $144.67 Now $144.46 +0.15% settles Feb 1
  5. Nov 2, 202614d ago 144 Neutral 2/10 Entry $144.67 Now $144.46 −0.15% settles Feb 1
  6. Oct 29, 202618d ago 8-K Neutral 5/10 Entry $146.33 Now $144.46 −1.28% settles Jan 27
  7. Oct 22, 202625d ago 3/A Neutral 1/10 Entry $145.27 Now $144.46 −0.56% settles Jan 21
  8. Oct 21, 202627d ago PTAB Trial Neutral 3/10 Entry $147.24 Now $144.46 −1.89% settles Jan 20
  9. Oct 15, 20264w ago PTAB Trial Bullish 6/10 Entry $145.95 Now $144.46 −1.02% settles Jan 13
  10. Oct 15, 20264w ago PTAB Trial Bullish 5/10 Entry $145.95 Now $144.46 −1.02% settles Jan 13
Showing 10 of 34

US Market Status

Market Closed · Opens Wed (9h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026